ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly effect of exchange rate changes on cash and equivalents ($M) ($M)
Quarterly figures from Eli Lilly's filings and investor materials
Latest, Q2 2026
-52
Period ended Jun 30, 2026
Change on a year earlier
-118.9%
275 in Q2 2025
History
68 quarters
Since Q3 2008
Sources
59
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Effect of exchange rate changes on cash and equivalents ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -52 | -118.9% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 67 | -49.2% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | -67.1 | -84.4% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | 32.1 | -85.9% | Form 10-Q (filed 2026-08-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 275 | -561.4% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 132 | -471.8% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | -429 | -430.6% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 227 | +4,181.1% | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | -59.6 | -747.8% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | -35.5 | -243.1% | Form 10-Q (filed 2024-04-30) ↗ |
| Q4 2023 | Dec 31, 2023 | 130 | -201.2% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 5.30 | -247.2% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2023 | Jun 30, 2023 | 9.20 | -113.3% | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | 24.8 | -26.2% | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2022 | Dec 31, 2022 | -128 | -41.9% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2022 | Sep 30, 2022 | -3.60 | -121.7% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | -69.4 | -907.0% | Form 10-Q (filed 2022-08-04) ↗ |
| Q1 2022 | Mar 31, 2022 | 33.6 | -429.4% | Form 10-Q (filed 2022-04-29) ↗ |
| Q4 2021 | Dec 31, 2021 | -221 | -204.0% | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | 16.6 | +2.5% | Form 10-Q (filed 2021-10-27) ↗ |
| Q2 2021 | Jun 30, 2021 | 8.60 | -84.2% | Form 10-Q (filed 2021-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | -10.2 | -84.7% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 212 | -706.3% | Form 10-K (filed 2021-02-17) ↗ |
| Q3 2020 | Sep 30, 2020 | 16.2 | -113.5% | Form 10-Q (filed 2020-10-28) ↗ |
| Q2 2020 | Jun 30, 2020 | 54.3 | +100.4% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | -66.7 | -276.5% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | -35 | -68.7% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2019 | Sep 30, 2019 | -120 | +774.5% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2019 | Jun 30, 2019 | 27.1 | -131.3% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2019 | Mar 31, 2019 | 37.8 | -74.5% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2018 | Dec 31, 2018 | -112 | +164.9% | Form 10-K (filed 2019-02-19) ↗ |
| Q3 2018 | Sep 30, 2018 | -13.7 | -144.8% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | -86.5 | +850.5% | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2018 | Mar 31, 2018 | 148 | +74,100.0% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | -42.2 | -65.0% | Form 10-K (filed 2018-02-20) ↗ |
| Q3 2017 | Sep 30, 2017 | 30.6 | -292.5% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2017 | Jun 30, 2017 | -9.10 | -69.6% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 0.20 | -100.3% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2016 | Dec 31, 2016 | -121 | -344.9% | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2016 | Sep 30, 2016 | -15.9 | -1.2% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | -29.9 | -147.5% | Form 10-Q (filed 2016-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | -70.1 | -61.4% | Form 10-Q (filed 2016-04-29) ↗ |
| Q4 2015 | Dec 31, 2015 | 49.2 | -152.7% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | -16.1 | -93.2% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | 62.9 | -1,410.4% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2015 | Mar 31, 2015 | -182 | +2,228.2% | Form 10-Q (filed 2015-04-30) ↗ |
| Q4 2014 | Dec 31, 2014 | -93.3 | – | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2014 | Sep 30, 2014 | -236 | – | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | -4.80 | +166.7% | Form 10-Q (filed 2014-07-28) ↗ |
| Q1 2014 | Mar 31, 2014 | -7.80 | -91.0% | Form 10-Q (filed 2014-04-28) ↗ |
| Q2 2013 | Jun 30, 2013 | -1.80 | -98.8% | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2013 | Mar 31, 2013 | -86.6 | -253.3% | Form 10-Q (filed 2013-04-26) ↗ |
| Q4 2012 | Dec 31, 2012 | 25.3 | – | Form 10-K (filed 2013-02-21) ↗ |
| Q3 2012 | Sep 30, 2012 | 107 | -196.6% | Form 10-Q (filed 2012-10-26) ↗ |
| Q2 2012 | Jun 30, 2012 | -144 | – | Form 10-Q (filed 2012-07-27) ↗ |
| Q1 2012 | Mar 31, 2012 | 56.5 | -38.3% | Form 10-Q (filed 2012-04-30) ↗ |
| Q2 2011 | Sep 30, 2011 | -110 | -165.5% | Form 10-Q (filed 2011-10-28) ↗ |
| Q1 2011 | Mar 31, 2011 | 91.6 | -195.3% | Form 10-Q (filed 2011-04-29) ↗ |
| Q4 2010 | Dec 31, 2010 | -29.6 | +40.3% | Form 10-K (filed 2011-02-22) ↗ |
| Q3 2010 | Sep 30, 2010 | 169 | +156.5% | Form 10-Q (filed 2010-10-29) ↗ |
| Q2 2010 | Jun 30, 2010 | -188 | -296.6% | Form 10-Q/A (filed 2010-08-02) ↗ |
| Q1 2010 | Mar 31, 2010 | -96.1 | -18.8% | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2009 | Dec 31, 2009 | -21.1 | -69.1% | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2009 | Sep 30, 2009 | 65.7 | -143.2% | Form 10-Q (filed 2009-10-30) ↗ |
| Q2 2009 | Jun 30, 2009 | 95.4 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q1 2009 | Mar 31, 2009 | -118 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2008 | Dec 31, 2008 | -68.3 | – | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2008 | Sep 30, 2008 | -152 | – | Form 10-Q (filed 2009-10-30) ↗ |
Cite this data
StockData. (2026). Eli Lilly Effect of exchange rate changes on cash and equivalents ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_fx_cash
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.